Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Teva Pharmaceuticals is recalling specific lots of Ethambutol Hydrochloride Tablets because they were manufactured with an unapproved gelatin excipient.
Aaron Industries is recalling Tussin CF Adult Maximum Strength Multi-Symptom Cold liquid due to the presence of a white precipitate, confirmed to be the active ingredient guaifenesin.
Caraco Pharmaceutical is recalling 2,528 bottles of Metformin HCl ER 500 mg tablets because a customer reported finding Gabapentin tablets in the bottle.
Actavis is recalling Gelnique (oxybutynin chloride) Gel 10% physician samples because drug potency was compromised during shipment.
Actavis Elizabeth LLC is recalling 13,608 bottles of Clonazepam 2 mg tablets because routine testing found one tablet with weight below specification.
Ranbaxy Inc. is recalling 64,626 bottles of Atorvastatin Calcium 10 mg tablets because a 20 mg tablet was found inside a sealed 10 mg bottle.
Gilead Sciences is recalling specific lots of Atripla tablets because they contain red silicone rubber particulates. The recall covers 39,223 bottles distributed nationwide.
Mylan Pharmaceuticals is recalling specific lots of Levothyroxine Sodium Tablets because stability testing showed the drug was below specification.
Actavis is recalling 99 cartons of Trelstar 11.25 mg due to a labeling error where the vial was marked 3.75 mg. The product was distributed nationwide and in Puerto Rico.
Caraco Pharmaceutical Laboratories is recalling 7,005 bottles of Oxcarbazepine 300 mg tablets because some tablets are broken.
Watson Laboratories is recalling Diclofenac Sodium and Misoprostol tablets because split tablets were found in stability samples.
Bracco Diagnostics Inc is recalling VoLumen Barium Sulfate Suspension because the product failed stability testing for preservative content.
B. Braun Medical Inc. is recalling 18,936 containers of Cefepime Hydrochloride and Dextrose Injection due to the presence of visible organic particulate matter.
Teva Pharmaceuticals USA is recalling Valacyclovir Hydrochloride 1 g tablets because bottles may contain fragments of Pravastatin tablets.
Baxter Healthcare is recalling 49,932 vials of Nitroglycerin in Dextrose Injection because particulate matter was found in one vial.
Health & Beyond is recalling Tranquility dietary supplements because they contain unapproved prescription drugs, Doxepin and Chlorpromazine.
Apothecure, Inc. is recalling all lots of sterile compounded products within expiry due to lack of sterility assurance identified during an FDA inspection.
Fusion Pharmaceuticals is recalling Dicopanol FusePaq Kits for Oral Suspension because they contain yeast and mold levels above USP limits.
Faria Limited LLC is recalling Dollar General Triple Antibiotic Ointment due to elevated counts of gram-positive rods found during environmental testing.
Insight Instruments is recalling Cornea Coat syringes because they were marketed without an approved NDA or ANDA.
Teva Pharmaceuticals USA is recalling specific lots of Hydralazine HCL 25 mg tablets because they may contain impurities outside of specification limits.
Teva Pharmaceuticals USA is recalling specific lots of Hydralazine HCL 50 mg tablets because they may fail impurity specifications throughout their shelf life.
Dr. Reddy's is recalling specific lots of Metoprolol Succinate Extended-Release Tablets because they failed dissolution specifications and a 12-month stability interval.
Sheffield Pharmaceuticals is recalling Sheffield Triple Antibiotic Ointment due to elevated counts of gram-positive rods found during environmental testing.
Actavis Inc is recalling 6,540 bottles of Diclofenac Sodium and Misoprostol tablets because some tablets are broken.